To provide for a limitation on availability of funds for the Western Hemisphere Drug Policy Commission, Salaries and Expenses for fiscal year 2024.

HR 2330 caps funding for the Western Hemisphere Drug Policy Commission's salaries and expenses at $1.5 million for fiscal year 2024. This bill directly affects the commission by restricting its budget authority for personnel and operational costs during FY2024. The key provision is a statutory limit preventing any use of funds exceeding $1.5 million for these specific purposes. The bill does not alter the commission's mission or create new policies, only setting a spending ceiling for its existing budget.